Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3328-3333

  Desbiolles, N ^a   Piroth, L ^a   Lequeu, C ^a   Neuwirth, C ^a   Portier, H ^a   Chavanet, P ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; GENTAMICIN; PENICILLIN G; VANCOMYCIN;

ARTICLE; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORINS; DRUG SYNERGISM; ENTEROCOCCUS FAECALIS; KINETICS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 0035178556     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3328-3333.2001     Document Type: Article

References (37)

1. Analysis of a new method for assessing activity of combinations of antimicrobials: Area under the bactericidal activity curve
2. Minor synergy and antagonism may be clinically important
3. Interactions of antimicrobial combinations in vitro: The relativity of synergism
4. The toxicity of poisons applied jointly
5. Epidemiology of emerging pneumococcal drug resistance: Implications for treatment and prevention
6. Comparison of methodologies for synergism testing of drug combinations against strains of Pseudomonas aeruginosa
7. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas
8. Experimental efficacy of combined ceftriaxone and amoxicillin on penicillin-resistant and broad-spectrum cephalosporinresistant Streptococcus pneumoniae infection
9. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995
10. Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin
11. Killing activities of trovafloxacin alone and in combination with β-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations achievable in cerebrospinal fluid
12. Evaluation of antimicrobial regimens for treatment of experimental penicillin and cephalosporin-resistant pneumococcal meningitis
13. Timekill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae
14. Consensus on concepts and terminology for combined-action assessment: The Saariselkä agreement
15. The search for synergy: A critical review from a response surface perspective
16. Rationalization of terminology and methodology in the study of antibiotic interaction
17. Antimicrobial therapy of experimental enterococcal endocarditis
18. The combined action of penicillin with streptomycin or chloromycetin on enterococci vitro
19. In vitro activity of a combination of two oral β-lactams (cefpodoxime and amoxicillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin
20. The assesment of antimicrobial combinations
21. Bacterial activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis Antimicrob
22. The fractional maximal effect method: A new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions
23. The problem of synergism and antagonism of combined drugs
24. Penicillin resistance and aminoglycoside-penicillin synergy in enterococci
25. A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative β-lactam, aminoglycoside and fluoroquinilone
26. Enterococcal endocarditis: An analysis of 38 patients observed at the New York Hospital Cornell Medical Center
27. In vitro susceptibility of Streptococcus pneumoniae strains to nine β-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin
28. Beta-lactam/ aminoglycoside combinations: Interactions and their mechanisms
29. Studies on antibiotic synergism against enterococci I. Bacteriological studies
30. Comparison of techniques for measurement of in vitro antibiotic synergism
31. Emergence of vancomycin tolerance in Streptococcus pneumoniae
32. Strategic design and three-dimensional analysis of antiviral drug combinations
33. Antibiotic combinations: The clinical relevance of synergy and antagonism
34. Methodological variation in antibiotic synergy tests against enterococci
35. Decimal assay for additivity of drugs permits delineation of synergy and antagonism